Complications following hepatectomy

Surgical Oncology Clinics of North America

Volumn 24, Issue 1, 2015, Pages 73-96

  Russell, Maria C ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Bile leak; Hepatectomy; Post hepatectomy liver failure; Venous thromboembolism

Indexed keywords

ALBUMIN; ANTICOAGULANT AGENT; BEVACIZUMAB; CETUXIMAB; DIURETIC AGENT; FIBRIN GLUE; FLUOROURACIL; FRESH FROZEN PLASMA; HEMOGLOBIN; HEPARIN; INDOCYANINE GREEN; IRINOTECAN; OXALIPLATIN; VITAMIN K GROUP; WARFARIN;

ANGIOPLASTY; ARTIFICIAL LIVER; BILE DUCT CARCINOMA; BILE LEAKAGE; BILIARY TRACT DRAINAGE; BLOOD CLOT LYSIS; BLOOD TRANSFUSION; CHEMOEMBOLIZATION; COLOR ULTRASOUND FLOWMETRY; COLORECTAL CANCER; COMORBIDITY; COMPRESSION INSTRUMENT; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DOPPLER ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FATTY LIVER; FLUORESCENCE ANGIOGRAPHY; HEPATIC ARTERY THROMBOSIS; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; LAPAROTOMY; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CONGESTION; LIVER FAILURE; LIVER RESECTION; LIVER SUPPORT; LIVER TRANSPLANTATION; LUNG EMBOLISM; MOBILIZATION; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PATIENT SAFETY; PATIENT SELECTION; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; RECURRENCE FREE SURVIVAL; REOPERATION; REVIEW; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURGICAL THROMBECTOMY; TREATMENT OUTCOME; UNITED STATES; VENOUS THROMBOEMBOLISM; ADVERSE EFFECTS; LIVER DISEASES;

HEPATECTOMY; HUMANS; LIVER DISEASES; POSTOPERATIVE COMPLICATIONS;

EID: 84922830493     PISSN: 10553207     EISSN: 15585042     Source Type: Journal    
DOI: 10.1016/j.soc.2014.09.008     Document Type: Review

References (174)

1. Dimick J.B., Wainess R.M., Cowan J.A., et al. National trends in the use and outcomes of hepatic resection. JAm Coll Surg 2004, 199:31-38.
2. Asiyanbola B., Chang D., Gleisner A.L., et al. Operative mortality after hepatic resection: are literature-based rates broadly applicable?. JGastrointest Surg 2008, 12:842-851.
3. Foster J.H., Berman M.M. Solid liver tumors. Major Probl Clin Surg 1977, 22:1-342.
4. Hyder O., Pulitano C., Firoozmand A., et al. Arisk model to predict 90-day mortality among patients undergoing hepatic resection. JAm Coll Surg 2013, 216:1049-1056.
5. Jarnagin W.R., Gonen M., Fong Y., et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002, 236:397-406. [discussion: 406-7].
6. Mullen J.T., Ribero D., Reddy S.K., et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. JAm Coll Surg 2007, 204:854-862. [discussion: 862-4].
7. McKay A., Sutherland F.R., Bathe O.F., et al. Morbidity and mortality following multivisceral resections in complex hepatic and pancreatic surgery. JGastrointest Surg 2008, 12:86-90.
8. Mathur A.K., Ghaferi A.A., Osborne N.H., et al. Body mass index and adverse perioperative outcomes following hepatic resection. JGastrointest Surg 2010, 14:1285-1291.
9. Benzoni E., Cojutti A., Lorenzin D., et al. Liver resective surgery: a multivariate analysis of postoperative outcome and complication. Langenbecks Arch Surg 2007, 392:45-54.
10. Sadamori H., Yagi T., Shinoura S., et al. Risk factors for major morbidity after liver resection for hepatocellular carcinoma. Br J Surg 2013, 100:122-129.
11. Virani S., Michaelson J.S., Hutter M.M., et al. Morbidity and mortality after liver resection: results of the patient safety in surgery study. JAm Coll Surg 2007, 204:1284-1292.
12. Zimmitti G., Roses R.E., Andreou A., et al. Greater complexity of liver surgery is not associated with an increased incidence of liver-related complications except for bile leak: an experience with 2,628 consecutive resections. JGastrointest Surg 2013, 17:57-64. [discussion: 64-5].
13. Li G.Z., Speicher P.J., Lidsky M.E., et al. Hepatic resection for hepatocellular carcinoma: do contemporary morbidity and mortality rates demand a transition to ablation as first-line treatment?. JAm Coll Surg 2014, 218:827-834.
14. Okuda K. Hepatocellular carcinoma. JHepatol 2000, 32:225-237.
15. Adam R., Azoulay D., Castaing D., et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?. Ann Surg 2003, 238:508-518. [discussion: 518-9].
16. Bigourdan J.M., Jaeck D., Meyer N., et al. Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl 2003, 9:513-520.
17. Cha C.H., Ruo L., Fong Y., et al. Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg 2003, 238:315-321. [discussion: 321-3].
18. Margarit C., Escartin A., Castells L., et al. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl 2005, 11:1242-1251.
19. Squires M.H., Hanish S.I., Fisher S.B., et al. Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times. JSurg Oncol 2014, 109:533-541.
20. Bismuth H., Majno P.E. Hepatobiliary surgery. JHepatol 2000, 32:208-224.
21. Arii S., Yamaoka Y., Futagawa S., et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000, 32:1224-1229.
22. Bruix J., Sherman M., Llovet J.M., et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. JHepatol 2001, 35:421-430.
23. Kooby D.A., Stockman J., Ben-Porat L., et al. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 2003, 237:860-869. [discussion: 869-70].
24. Rahbari N.N., Garden O.J., Padbury R., et al. Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS). HPB (Oxford) 2011, 13:528-535.
25. Belghiti J., Hiramatsu K., Benoist S., et al. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. JAm Coll Surg 2000, 191:38-46.
26. Schroeder R.A., Marroquin C.E., Bute B.P., et al. Predictive indices of morbidity and mortality after liver resection. Ann Surg 2006, 243:373-379.
27. Lim C., Dokmak S., Farges O., et al. Reoperation for post-hepatectomy hemorrhage: increased risk of mortality. Langenbecks Arch Surg 2014, 399:735-740.
28. Fujii M., Shimada M., Satoru I., et al. Astandardized safe hepatectomy; selective Glissonean transection using endolinear stapling devices. Hepatogastroenterology 2007, 54:906-909.
29. Fujii Y., Shimada H., Endo I., et al. Management of massive arterial hemorrhage after pancreatobiliary surgery: does embolotherapy contribute to successful outcome?. JGastrointest Surg 2007, 11:432-438.
30. Ogata S., Belghiti J., Farges O., et al. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg 2006, 93:1091-1098.
31. Cho J.Y., Suh K.S., Kwon C.H., et al. Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired. Surgery 2006, 139:508-515.
32. Azoulay D., Lucidi V., Andreani P., et al. Ischemic preconditioning for major liver resection under vascular exclusion of the liver preserving the caval flow: a randomized prospective study. JAm Coll Surg 2006, 202:203-211.
33. Vauthey J.N., Pawlik T.M., Abdalla E.K., et al. Is extended hepatectomy for hepatobiliary malignancy justified?. Ann Surg 2004, 239:722-730. [discussion: 730-2].
34. Yang T., Li L., Zhong Q., et al. Risk factors of hospital mortality after re-laparotomy for post-hepatectomy hemorrhage. World J Surg 2013, 37:2394-2401.
35. Jin S., Fu Q., Wuyun G., et al. Management of post-hepatectomy complications. World J Gastroenterol 2013, 19:7983-7991.
36. Tsao J.I., Loftus J.P., Nagorney D.M., et al. Trends in morbidity and mortality of hepatic resection for malignancy. A matched comparative analysis. Ann Surg 1994, 220:199-205.
37. Finch M.D., Crosbie J.L., Currie E., et al. An 8-year experience of hepatic resection: indications and outcome. Br J Surg 1998, 85:315-319.
38. Sitzmann J.V., Greene P.S. Perioperative predictors of morbidity following hepatic resection for neoplasm. A multivariate analysis of a single surgeon experience with 105 patients. Ann Surg 1994, 219:13-17.
39. Catheline J.M., Capelluto E., Gaillard J.L., et al. Thromboembolism prophylaxis and incidence of thromboembolic complications after laparoscopic surgery. Int J Surg Investig 2000, 2:41-47.
40. Agnelli G., Bolis G., Capussotti L., et al. Aclinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 2006, 243:89-95.
41. Alcalay A., Wun T., Khatri V., et al. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. JClin Oncol 2006, 24:1112-1118.
42. Flinterman L.E., van Hylckama Vlieg A., Cannegieter S.C., et al. Long-term survival in a large cohort of patients with venous thrombosis: incidence and predictors. PLoS Med 2012, 9:e1001155.
43. Ng A.C., Chung T., Yong A.S., et al. Long-term cardiovascular and noncardiovascular mortality of 1023 patients with confirmed acute pulmonary embolism. Circ Cardiovasc Qual Outcomes 2011, 4:122-128.
44. Sogaard K.K., Schmidt M., Pedersen L., et al. 30-year mortality following venous thromboembolism: a population-based cohort study. Circulation 2014, 130:829-836.
45. Tzeng C.W., Katz M.H., Fleming J.B., et al. Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB (Oxford) 2012, 14:506-513.
46. Reddy S.K., Turley R.S., Barbas A.S., et al. Post-operative pharmacologic thromboprophylaxis after major hepatectomy: does peripheral venous thromboembolism prevention outweigh bleeding risks?. JGastrointest Surg 2011, 15:1602-1610.
47. Kakkar A.K., Levine M., Pinedo H.M., et al. Venous thrombosis in cancer patients: insights from the FRONTLINE survey. Oncologist 2003, 8:381-388.
48. De Martino R.R., Goodney P.P., Spangler E.L., et al. Variation in thromboembolic complications among patients undergoing commonly performed cancer operations. JVasc Surg 2012, 55:1035-1040.e4.
49. Nathan H., Weiss M.J., Soff G.A., et al. Pharmacologic prophylaxis, postoperative INR, and risk of venous thromboembolism after hepatectomy. JGastrointest Surg 2014, 18:295-302. [discussion: 302-3].
50. Melloul E., Dondero F., Vilgrain V., et al. Pulmonary embolism after elective liver resection: a prospective analysis of risk factors. JHepatol 2012, 57:1268-1275.
51. Morris-Stiff G., White A., Gomez D., et al. Thrombotic complications following liver resection for colorectal metastases are preventable. HPB (Oxford) 2008, 10:311-314.
52. Ejaz A., Spolverato G., Kim Y., et al. Defining incidence and risk factors of venous thromboembolism after hepatectomy. JGastrointest Surg 2014, 18:1116-1124.
53. Chitlur M. Challenges in the laboratory analyses of bleeding disorders. Thromb Res 2012, 130:1-6.
54. Collins R., Scrimgeour A., Yusuf S., et al. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. NEngl J Med 1988, 318:1162-1173.
55. Mismetti P., Laporte S., Darmon J.Y., et al. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 2001, 88:913-930.
56. Azoulay D., Pascal G., Salloum C., et al. Vascular reconstruction combined with liver resection for malignant tumours. Br J Surg 2013, 100:1764-1775.
57. Silva M.A., Jambulingam P.S., Gunson B.K., et al. Hepatic artery thrombosis following orthotopic liver transplantation: a 10-year experience from a single centre in the United Kingdom. Liver Transpl 2006, 12:146-151.
58. Bhattacharjya S., Gunson B.K., Mirza D.F., et al. Delayed hepatic artery thrombosis in adult orthotopic liver transplantation-a 12-year experience. Transplantation 2001, 71:1592-1596.
59. Woo D.H., Laberge J.M., Gordon R.L., et al. Management of portal venous complications after liver transplantation. Tech Vasc Interv Radiol 2007, 10:233-239.
60. Wozney P., Zajko A.B., Bron K.M., et al. Vascular complications after liver transplantation: a 5-year experience. AJR Am J Roentgenol 1986, 147:657-663.
61. Cohen J., Edelman R.R., Chopra S. Portal vein thrombosis: a review. Am J Med 1992, 92:173-182.
62. Witte C.L., Brewer M.L., Witte M.H., et al. Protean manifestations of pylethrombosis. A review of thirty-four patients. Ann Surg 1985, 202:191-202.
63. Sheen C.L., Lamparelli H., Milne A., et al. Clinical features, diagnosis and outcome of acute portal vein thrombosis. QJM 2000, 93:531-534.
64. Abbas S., Sandroussi C. Systematic review and meta-analysis of the role of vascular resection in the treatment of hilar cholangiocarcinoma. HPB (Oxford) 2013, 15:492-503.
65. Varotti G., Grazi G.L., Vetrone G., et al. Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. Clin Transplant 2005, 19:492-500.
66. Langnas A.N., Marujo W., Stratta R.J., et al. Vascular complications after orthotopic liver transplantation. Am J Surg 1991, 161:76-82. [discussion: 82-3].
67. Iida T., Kaido T., Yagi S., et al. Hepatic arterial complications in adult living donor liver transplant recipients: a single-center experience of 673 cases. Clin Transplant 2014, 28:1025-1030.
68. Thomas R.M., Ahmad S.A. Management of acute post-operative portal venous thrombosis. JGastrointest Surg 2010, 14:570-577.
69. Condat B., Pessione F., Hillaire S., et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology 2001, 120:490-497.
70. Turnes J., Garcia-Pagan J.C., Gonzalez M., et al. Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulation. Clin Gastroenterol Hepatol 2008, 6:1412-1417.
71. Plessier A., Darwish-Murad S., Hernandez-Guerra M., et al. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology 2010, 51:210-218.
72. Sobhonslidsuk A., Reddy K.R. Portal vein thrombosis: a concise review. Am J Gastroenterol 2002, 97:535-541.
73. Bhattacharjya T., Olliff S.P., Bhattacharjya S., et al. Percutaneous portal vein thrombolysis and endovascular stent for management of posttransplant portal venous conduit thrombosis. Transplantation 2000, 69:2195-2198.
74. Yamashita Y., Hamatsu T., Rikimaru T., et al. Bile leakage after hepatic resection. Ann Surg 2001, 233:45-50.
75. Imamura H., Seyama Y., Kokudo N., et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 2003, 138:1198-1206. [discussion: 1206].
76. Lo C.M., Fan S.T., Liu C.L., et al. Biliary complications after hepatic resection: risk factors, management, and outcome. Arch Surg 1998, 133:156-161.
77. Capussotti L., Ferrero A., Vigano L., et al. Bile leakage and liver resection: Where is the risk?. Arch Surg 2006, 141:690-694. [discussion: 695].
78. Rahbari N.N., Garden O.J., Padbury R., et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 2011, 149:713-724.
79. Kohno H., Nagasue N., Chang Y.C., et al. Comparison of topical hemostatic agents in elective hepatic resection: a clinical prospective randomized trial. World J Surg 1992, 16:966-969. [discussion: 970].
80. Bismuth H., Chiche L., Castaing D. Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections. World J Surg 1995, 19:35-41.
81. Lai E.C., Fan S.T., Lo C.M., et al. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg 1995, 221:291-298.
82. Nagano Y., Togo S., Tanaka K., et al. Risk factors and management of bile leakage after hepatic resection. World J Surg 2003, 27:695-698.
83. Sadamori H., Yagi T., Matsuda H., et al. Risk factors for major morbidity after hepatectomy for hepatocellular carcinoma in 293 recent cases. JHepatobiliary Pancreat Sci 2010, 17:709-718.
84. Yamanaka N., Okamoto E., Kuwata K., et al. Amultiple regression equation for prediction of posthepatectomy liver failure. Ann Surg 1984, 200:658-663.
85. Okumura K., Sugimachi K., Kinjo N., et al. Risk factors of bile leakage after hepatectomy for hepatocellular carcinoma. Hepatogastroenterology 2013, 60:1717-1719.
86. Kim J., Ahmad S.A., Lowy A.M., et al. Increased biliary fistulas after liver resection with the harmonic scalpel. Am Surg 2003, 69:815-819.
87. Weber J.C., Navarra G., Jiao L.R., et al. New technique for liver resection using heat coagulative necrosis. Ann Surg 2002, 236:560-563.
88. Poon R.T., Fan S.T., Wong J. Liver resection using a saline-linked radiofrequency dissecting sealer for transection of the liver. JAm Coll Surg 2005, 200:308-313.
89. Delis S.G., Bakoyiannis A., Karakaxas D., et al. Hepatic parenchyma resection using stapling devices: peri-operative and long-term outcome. HPB (Oxford) 2009, 11:38-44.
90. Castaldo E.T., Earl T.M., Chari R.S., et al. Aclinical comparative analysis of crush/clamp, stapler, and dissecting sealer hepatic transection methods. HPB (Oxford) 2008, 10:321-326.
91. Romano F., Garancini M., Caprotti R., et al. Hepatic resection using a bipolar vessel sealing device: technical and histological analysis. HPB (Oxford) 2007, 9:339-344.
92. Geller D.A., Tsung A., Maheshwari V., et al. Hepatic resection in 170 patients using saline-cooled radiofrequency coagulation. HPB (Oxford) 2005, 7:208-213.
93. Alexiou V.G., Tsitsias T., Mavros M.N., et al. Technology-assisted versus clamp-crush liver resection: a systematic review and meta-analysis. Surg Innov 2013, 20:414-428.
94. Kobayashi S., Nagano H., Marubashi S., et al. Fibrin sealant with PGA felt for prevention of bile leakage after liver resection. Hepatogastroenterology 2012, 59:2564-2568.
95. Sanjay P., Watt D.G., Wigmore S.J. Systematic review and meta-analysis of haemostatic and biliostatic efficacy of fibrin sealants in elective liver surgery. JGastrointest Surg 2013, 17:829-836.
96. Nanashima A., Tobinaga S., Abo T., et al. Usefulness of omental wrapping to prevent biliary leakage and delayed gastric emptying in left hepatectomy. Hepatogastroenterology 2012, 59:847-850.
97. de Boer M.T., Boonstra E.A., Lisman T., et al. Role of fibrin sealants in liver surgery. Dig Surg 2012, 29:54-61.
98. Zimmitti G., Vauthey J.N., Shindoh J., et al. Systematic use of an intraoperative air leak test at the time of major liver resection reduces the rate of postoperative biliary complications. JAm Coll Surg 2013, 217:1028-1037.
99. Lam C.M., Lo C.M., Liu C.L., et al. Biliary complications during liver resection. World J Surg 2001, 25:1273-1276.
100. Ijichi M., Takayama T., Toyoda H., et al. Randomized trial of the usefulness of a bile leakage test during hepatic resection. Arch Surg 2000, 135:1395-1400.
101. Li J., Malago M., Sotiropoulos G.C., et al. Intraoperative application of "white test" to reduce postoperative bile leak after major liver resection: results of a prospective cohort study in 137 patients. Langenbecks Arch Surg 2009, 394:1019-1024.
102. Kaibori M., Ishizaki M., Matsui K., et al. Intraoperative indocyanine green fluorescent imaging for prevention of bile leakage after hepatic resection. Surgery 2011, 150:91-98.
103. Tanaka S., Hirohashi K., Tanaka H., et al. Incidence and management of bile leakage after hepatic resection for malignant hepatic tumors. JAm Coll Surg 2002, 195:484-489.
104. Vigano L., Ferrero A., Sgotto E., et al. Bile leak after hepatectomy: predictive factors of spontaneous healing. Am J Surg 2008, 196:195-200.
105. Sherman S., Shaked A., Cryer H.M., et al. Endoscopic management of biliary fistulas complicating liver transplantation and other hepatobiliary operations. Ann Surg 1993, 218:167-175.
106. Cheung K.L., Lai E.C. Endoscopic stenting for malignant biliary obstruction. Arch Surg 1995, 130:204-207.
107. Pace R.F., Blenkharn J.I., Edwards W.J., et al. Intra-abdominal sepsis after hepatic resection. Ann Surg 1989, 209:302-306.
108. Capussotti L., Muratore A., Amisano M., et al. Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival-a European single center experience. Eur J Surg Oncol 2005, 31:986-993.
109. Chok K.S., Ng K.K., Poon R.T., et al. Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma. Br J Surg 2009, 96:81-87.
110. Kawano Y., Sasaki A., Kai S., et al. Short- and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis. Ann Surg Oncol 2008, 15:1670-1676.
111. Mizuguchi T., Nagayama M., Meguro M., et al. Prognostic impact of surgical complications and preoperative serum hepatocyte growth factor in hepatocellular carcinoma patients after initial hepatectomy. JGastrointest Surg 2009, 13:325-333.
112. Okamura Y., Takeda S., Fujii T., et al. Prognostic significance of postoperative complications after hepatectomy for hepatocellular carcinoma. JSurg Oncol 2011, 104:814-821.
113. Paugam-Burtz C., Janny S., Delefosse D., et al. Prospective validation of the "fifty-fifty" criteria as an early and accurate predictor of death after liver resection in intensive care unit patients. Ann Surg 2009, 249:124-128.
114. Detroz B., Sugarbaker P.H., Knol J.A., et al. Causes of death in patients undergoing liver surgery. Cancer Treat Res 1994, 69:241-257.
115. Simmonds P.C., Primrose J.N., Colquitt J.L., et al. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 2006, 94:982-999.
116. Garcea G., Maddern G.J. Liver failure after major hepatic resection. JHepatobiliary Pancreat Surg 2009, 16:145-155.
117. McCall J., Koea J., Gunn K., et al. Liver resections in Auckland 1998-2001: mortality, morbidity and blood product use. NZ Med J 2001, 114:516-519.
118. Sun H.C., Qin L.X., Wang L., et al. Risk factors for postoperative complications after liver resection. Hepatobiliary Pancreat Dis Int 2005, 4:370-374.
119. Schindl M.J., Redhead D.N., Fearon K.C., et al. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 2005, 54:289-296.
120. Pawlik T.M., Olino K., Gleisner A.L., et al. Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. JGastrointest Surg 2007, 11:860-868.
121. Zorzi D., Chun Y.S., Madoff D.C., et al. Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases. Ann Surg Oncol 2008, 15:2765-2772.
122. Adam R., Aloia T., Levi F., et al. Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. JClin Oncol 2007, 25:4593-4602.
123. Balzan S., Belghiti J., Farges O., et al. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 2005, 242:824-828. [discussion: 828-9].
124. Etra J.W., Squires M.H., Fisher S.B., et al. Early identification of patients at increased risk for hepatic insufficiency, complications and mortality after major hepatectomy. HPB (Oxford) 2014, 16:875-883.
125. Menon K.V., Al-Mukhtar A., Aldouri A., et al. Outcomes after major hepatectomy in elderly patients. JAm Coll Surg 2006, 203:677-683.
126. Aldrighetti L., Arru M., Caterini R., et al. Impact of advanced age on the outcome of liver resection. World J Surg 2003, 27:1149-1154.
127. Ferrero A., Vigano L., Polastri R., et al. Hepatectomy as treatment of choice for hepatocellular carcinoma in elderly cirrhotic patients. World J Surg 2005, 29:1101-1105.
128. Hanazaki K., Kajikawa S., Shimozawa N., et al. Hepatic resection for hepatocellular carcinoma in the elderly. JAm Coll Surg 2001, 192:38-46.
129. Mastoraki A., Tsakali A., Papanikolaou I.S., et al. Outcome following major hepatic resection in the elderly patients. Clin Res Hepatol Gastroenterol 2014, 38:462-466.
130. Alfieri S., Carriero C., Caprino P., et al. Avoiding early postoperative complications in liver surgery. A multivariate analysis of 254 patients consecutively observed. Dig Liver Dis 2001, 33:341-346.
131. Koperna T., Kisser M., Schulz F. Hepatic resection in the elderly. World J Surg 1998, 22:406-412.
132. Fernandes A.I., Tralhao J.G., Abrantes A., et al. Functional hepatocellular regeneration in elderly patients undergoing hepatectomy. Liver Int 2013, [Epub ahead of print].
133. Shoup M., Gonen M., D'Angelica M., et al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. JGastrointest Surg 2003, 7:325-330.
134. Brouquet A., Nordlinger B. Neoadjuvant therapy of colorectal liver metastases: lessons learned from clinical trials. JSurg Oncol 2010, 102:932-936.
135. Fowler W.C., Eisenberg B.L., Hoffman J.P. Hepatic resection following systemic chemotherapy for metastatic colorectal carcinoma. JSurg Oncol 1992, 51:122-125.
136. Bismuth H., Adam R., Levi F., et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996, 224:509-520. [discussion: 520-2].
137. Shankar A., Leonard P., Renaut A.J., et al. Neo-adjuvant therapy improves resectability rates for colorectal liver metastases. Ann R Coll Surg Engl 2001, 83:85-88.
138. King P.D., Perry M.C. Hepatotoxicity of chemotherapy. Oncologist 2001, 6:162-176.
139. Makuuchi M., Kokudo N., Arii S., et al. Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res 2008, 38:37-51.
140. Rubbia-Brandt L., Lauwers G.Y., Wang H., et al. Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology 2010, 56:430-439.
141. Soubrane O., Brouquet A., Zalinski S., et al. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome. Ann Surg 2010, 251:454-460.
142. Karoui M., Penna C., Amin-Hashem M., et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastatses. Ann Surg 2006, 243(1):1-7.
143. Shindoh J., Tzeng C.W., Aloia T.A., et al. Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases. Ann Surg Oncol 2013, 20(8):2493-2500.
144. Fong Y., Sun R.L., Jarnagin W., et al. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999, 229:790-799. [discussion: 799-800].
145. Midorikawa Y., Kubota K., Takayama T., et al. Acomparative study of postoperative complications after hepatectomy in patients with and without chronic liver disease. Surgery 1999, 126:484-491.
146. Poon R.T., Fan S.T., Lo C.M., et al. Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified?. Ann Surg 2002, 236:602-611.
147. Hsu K.Y., Chau G.Y., Lui W.Y., et al. Predicting morbidity and mortality after hepatic resection in patients with hepatocellular carcinoma: the role of Model for End-Stage Liver Disease score. World J Surg 2009, 33:2412-2419.
148. Choi G.H., Park J.Y., Hwang H.K., et al. Predictive factors for long-term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinoma. Liver Int 2011, 31:485-493.
149. Ruzzenente A., Valdegamberi A., Campagnaro T., et al. Hepatocellular carcinoma in cirrhotic patients with portal hypertension: is liver resection always contraindicated?. World J Gastroenterol 2011, 17:5083-5088.
150. Cucchetti A., Ercolani G., Vivarelli M., et al. Is portal hypertension a contraindication to hepatic resection?. Ann Surg 2009, 250:922-928.
151. Capussotti L., Ferrero A., Vigano L., et al. Portal hypertension: contraindication to liver surgery?. World J Surg 2006, 30:992-999.
152. Scheingraber S., Richter S., Igna D., et al. Indocyanine green disappearance rate is the most useful marker for liver resection. Hepatogastroenterology 2008, 55:1394-1399.
153. Kubota K., Makuuchi M., Kusaka K., et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997, 26:1176-1181.
154. Shirabe K., Shimada M., Gion T., et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. JAm Coll Surg 1999, 188:304-309.
155. Zorzi D., Laurent A., Pawlik T.M., et al. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 2007, 94:274-286.
156. Makuuchi M., Kosuge T., Takayama T., et al. Surgery for small liver cancers. Semin Surg Oncol 1993, 9:298-304.
157. de Santibanes E., Alvarez F.A., Ardiles V. How to avoid postoperative liver failure: a novel method. World J Surg 2012, 36:125-128.
158. Vauthey J.N., Chaoui A., Do K.A., et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 2000, 127:512-519.
159. Clavien P.A., Selzner M., Rudiger H.A., et al. Aprospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003, 238:843-850. [discussion: 851-2].
160. Serafin A., Rosello-Catafau J., Prats N., et al. Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol 2002, 161:587-601.
161. Petrowsky H., McCormack L., Trujillo M., et al. Aprospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection. Ann Surg 2006, 244:921-928. [discussion: 928-30].
162. Jin S., Dai C.L. Hepatic blood inflow occlusion without hemihepatic artery control in treatment of hepatocellular carcinoma. World J Gastroenterol 2010, 16:5895-5900.
163. van den Broek M.A., Olde Damink S.W., Dejong C.H., et al. Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int 2008, 28:767-780.
164. Jensen L.S., Andersen A.J., Christiansen P.M., et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992, 79:513-516.
165. Lipka J.M., Zibari G.B., Dies D.F., et al. Spontaneous bacterial peritonitis in liver failure. Am Surg 1998, 64:1155-1157.
166. Schreckenbach T., Liese J., Bechstein W.O., et al. Posthepatectomy liver failure. Dig Surg 2012, 29:79-85.
167. van de Kerkhove M.P., de Jong K.P., Rijken A.M., et al. MARS treatment in posthepatectomy liver failure. Liver Int 2003, 23(Suppl 3):44-51.
168. Chiu A., Chan L.M., Fan S.T. Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience. Liver Int 2006, 26:695-702.
169. Sisko A., Truffer C., Smith S., et al. Health spending projections through 2018: recession effects add uncertainty to the outlook. Health Aff (Millwood) 2009, 28:w346-w357.
170. Birkmeyer J.D., Dimick J.B., Birkmeyer N.J. Measuring the quality of surgical care: structure, process, or outcomes?. JAm Coll Surg 2004, 198:626-632.
171. Barkun J.S., Aronson J.K., Feldman L.S., et al. Evaluation and stages of surgical innovations. Lancet 2009, 374:1089-1096.
172. Ergina P.L., Cook J.A., Blazeby J.M., et al. Challenges in evaluating surgical innovation. Lancet 2009, 374:1097-1104.
173. Vonlanthen R., Slankamenac K., Breitenstein S., et al. The impact of complications on costs of major surgical procedures: a cost analysis of 1200 patients. Ann Surg 2011, 254:907-913.
174. Lucas D.J., Sweeney J.F., Pawlik T.M. The timing of complications impacts risk of readmission after hepatopancreatobiliary surgery. Surgery 2014, 155:945-953.